The disposition of the anti-inflammatory agent 14C-1-(p-chlorobenzoyl)-2-methyl-5-methoxy-3-indolylacetohydroxamic acid (oxametacine) in the rat.
D000818:Animals; D005243:Feces / Q000032:analysis; D005260:Female; D007213:Indomethacin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000378:metabolism; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007700:Kinetics; D008297:Male; D051381:Rats; D013997:Time Factors; D014018:Tissue Distribution
D007213:Indomethacin